01 6Palynziq
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2020 Revenue in Millions : 171
2019 Revenue in Millions : 87
Growth (%) : 97
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2021 Revenue in Millions : 238
2020 Revenue in Millions : 171
Growth (%) : 39
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2022 Revenue in Millions : 255
2021 Revenue in Millions : 237
Growth (%) : 7
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2023 Revenue in Millions : 304
2022 Revenue in Millions : 255
Growth (%) : 19
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2018 Revenue in Millions : 12
2017 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2019 Revenue in Millions : 87
2018 Revenue in Millions : 12
Growth (%) : 612
LOOKING FOR A SUPPLIER?
